GSK Investigational Site

L'Eliana, Valencia 46183

0 studies enrolling now · 2 studies all time

What they study most

Measles, Measles-Mumps-Rubella Vaccine, Mumps, Rubella

Studies at this site

• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life — Completed
• Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age — Completed